Antihyperlipidemic, Hepatoprotective, And Antioxidant Activity of a Polyherbal Extract of Aporosa Bourdillonii and Cadia Purpurea in High Fat Diet-Induced Hyperlipidaemic Wistar Rats

References

[1] World Health Organization. Cardiovascular diseases (CVDs): Key facts. Geneva: WHO; 2023.

[2] Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021.

[3] Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: AHA/NHLBI Scientific Statement. Circulation. 2005;112(17):2735–2752.

[4] Liu T, Zhao D, Qi Y. Global trends in the epidemiology and management of dyslipidaemia. J Clin Med. 2022;11(21):6377.

[5] Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607.

[6] Grundy SM. Hypertriglyceridaemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999;83(9B):25F–29F.

[7] Maiolino G, Rossitto G, Caielli P, et al. The role of oxidized low-density lipoproteins in atherosclerosis. Mediators Inflamm. 2013;2013:714653.

[8] Katzung BG. Basic and Clinical Pharmacology. 14th ed. New York: McGraw-Hill Education; 2018.

[9] Rang HP, Dale MM, Ritter JM, Flower RJ. Rang and Dale's Pharmacology. 9th ed. London: Elsevier; 2019.

[10] Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713–1722.

[11] Trease GE, Evans WC. Pharmacognosy. 16th ed. London: Saunders Elsevier; 2009.

[12] Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: concept of Ayurveda. Pharmacogn Rev. 2014;8(16):73–80.

[13] Plants of the World Online. Aporosa bourdillonii Stapf. Royal Botanic Gardens, Kew; 2023.

[14] Kiros T, Eswaramoorthy R, Melaku Y, Dekebo A. In vitro antibacterial and antioxidant activities of Cadia purpurea root extracts. J Trop Med. 2022;2022:4190166.

[15] IUCN Red List of Threatened Species. Aporosa bourdillonii: assessment report. IUCN; 2020.

[16] OECD. Guidelines for Testing of Chemicals: Acute Oral Toxicity — Acute Toxic Class Method (OECD 423). Paris: OECD; 2001.

[17] Patel DK, Kumar R, Laloo D, Hemalatha S. Polyherbal formulation of Terminalia arjuna and Emblica officinalis for antihyperlipidaemic activity in HFD rats. J Ethnopharmacol. 2024;318:116955.

[18] Singh N, Gupta SS. Antioxidant and hepatoprotective activity of Phyllanthus amarus in CCl₄-induced liver injury. Phytother Res. 2024;38(2):478–492.

[19] Chen Y, Liu X, Zhang H, Wang J. Quercetin-enriched flavonoid extract reduces LDL-C via HMG-CoA reductase inhibition in HFD rats. Food Funct. 2023;14(8):3781–3796.

[20] Nair PK, Pillai SS. Pharmacological screening of Malpighiales plants endemic to Western Ghats, India. J Nat Prod. 2023;86(5):1124–1138.

[21] Rahman MM, Islam MB, Biswas M, Alam AHMK. Antihyperlipidaemic activity of saponin-enriched Cassia fistula extract. Asian Pac J Trop Biomed. 2023;13(1):12–24.

[22] Tripathi AK, Gupta S. Mechanisms of cholesterol absorption inhibition by dietary saponins. J Agric Food Chem. 2022;70(12):3574–3587.

[23] Deore SL, Khadabadi SS, Baviskar BA. Hydrolysable tannins from Terminalia chebula: pancreatic lipase inhibition in HFD rats. Phytomedicine. 2022;98:153926.

[24] Mondal S, Bhattacharya S, Biswas M. Comparative evaluation of solvent systems for extraction of Phyllanthus niruri. J Pharm Pharmacol. 2022;74(3):412–424.

[25] Bhatt DL, Shah NM. Validation of high fat diet-induced hyperlipidaemia model in Wistar rats. Indian J Pharmacol. 2021;53(4):278–289.

[26] Kumar V, Chauhan NS. Phenolic acids attenuate LDL oxidation in HFD hyperlipidaemic rats. Cardiovasc Toxicol. 2021;21(7):548–562.

[27] Naidu PB, Uddandrao VVS, Naik RR, Suresh V. Hepatoprotective activity of Phyllanthus niruri: modulation of SREBP-1c and PPARα. J Hepatol Res. 2021;7(2):88–102.

[28] Goyal M, Sasmal D, Nagori BP. Atherogenic index of plasma as endpoint in polyherbal antihyperlipidaemic evaluation. J Cardiovasc Pharmacol. 2020;76(3):312–322.

[29] Wani TA, Zargar S, Majid S, Mir SR. Berberine suppresses PCSK9 and upregulates LDL receptor in HepG2 cells. Eur J Pharmacol. 2020;881:173191.

[30] Misra MK, Singh S. Oxidative stress biomarkers as endpoints in antihyperlipidaemic drug evaluation. Free Radic Biol Med. 2019;141:213–226.

[31] Jain P, Vyas M, Olennikov D, Khan IA. Phytochemistry of Phyllanthaceae: a comprehensive review. Phytochem Rev. 2018;17(4):681–718.

[32] Krishnamurthy S, Jose B, Thomas G. Ethnobotanical survey and antihyperlipidaemic screening of Western Ghats tribal plants. J Ethnobiol Ethnomed. 2017;13:52.

[33] Lakshmi BVS, Sudhakar M. Ursolic acid reduces VLDL-C and TG in HFD rats via DGAT1/PPARα modulation. Life Sci. 2016;144:168–177.

[34] Thomas S, Kuruvilla KM. Ethnobotanical documentation and antihyperlipidaemic screening of Kerala medicinal plants. J Ethnopharmacol. 2014;158(Pt A):228–241.

[35] Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470–475.

[36] Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(10):2077–2080.

[37] Burstein M, Scholnick HR, Morfin R. Rapid method for isolation of lipoproteins by precipitation with polyanions. J Lipid Res. 1970;11(6):583–595.

[38] Friedewald WT, Levy RI, Fredrickson DS. Estimation of LDL-C in plasma without ultracentrifuge. Clin Chem. 1972;18(6):499–502.

[39] Reitman S, Frankel S. A colorimetric method for serum glutamic oxalacetic and pyruvic transaminases. Am J Clin Pathol. 1957;28(1):56–63.

[40] Kind PRN, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol. 1954;7(4):322–326.

[41] Marklund S, Marklund G. Involvement of superoxide anion in autoxidation of pyrogallol: assay for SOD. Eur J Biochem. 1974;47(3):469–474.

[42] Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126.

[43] Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77.

[44] Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–358.

[45] Bradford MM. A rapid method for the quantitation of protein utilizing protein-dye binding. Anal Biochem. 1976;72(1-2):248–254.

[46] Gamble J. Plant Resources of South-East Asia No. 6: Rattans. Bogor: PROSEA Foundation; 1992.

[47] Bridson EE, Forman L. The Herbarium Handbook. 3rd ed. London: Royal Botanic Gardens, Kew; 1992.

[48] Harborne JB. Phytochemical Methods. 3rd ed. London: Chapman & Hall; 1998.

[49] Kokate CK. Practical Pharmacognosy. 4th ed. New Delhi: Vallabh Prakashan; 2010.

[50] Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16(3):144–158.

[51] Chang CC, Yang MH, Wen HM, Chern JC. Estimation of total flavonoid content in propolis by two colorimetric methods. J Food Drug Anal. 2002;10(3):178–182.

[52] CPCSEA. Guidelines for Laboratory Animal Facility. Government of India; 2006.

[53] Bancroft JD, Layton C. Bancroft's Theory and Practice of Histological Techniques. 8th ed. London: Elsevier; 2019.

@article{1718799,
      author = {Rakesh Kumar Gupta, Swapnil Pandey},
      title = {Antihyperlipidemic, Hepatoprotective, And Antioxidant Activity of a Polyherbal Extract of Aporosa Bourdillonii and Cadia Purpurea in High Fat Diet-Induced Hyperlipidaemic Wistar Rats},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {12},
      pages = {950-960},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718799.pdf},
      abstract = {Background: Hyperlipidaemia is among the most prevalent metabolic disorders globally and a primary risk factor for cardiovascular disease. Synthetic antihyperlipidemic drugs, while efficacious, carry significant adverse effects including myopathy, hepatotoxicity, and high cost, driving the search for safer phytopharmaceutical alternatives. Objectives: This study evaluated the antihyperlipidemic, hepatoprotective, and antioxidant activities of a hydroalcoholic polyherbal extract (PHE) combining Aporosa bourdillonii Stapf (Phyllanthaceae) and Cadia purpurea (G.Piccioli) Aiton (Fabaceae) in a high fat diet (HFD)-induced hyperlipidaemic Wistar albino rat model. Methods: PHE was prepared by Soxhlet extraction (70% ethanol) and administered orally at 200 and 400 mg/kg body weight for 28 days alongside HFD, with atorvastatin (10 mg/kg) as reference. Parameters assessed included serum lipid profile, atherogenic indices (AIP, CRI-I, CRI-II), liver function markers (ALT, AST, ALP), hepatic antioxidant enzyme activities (SOD, CAT, GPx), malondialdehyde (MDA), and histopathological evaluation. Results: PHE at 400 mg/kg significantly reduced serum total cholesterol (−36.4%), triglycerides (−34.1%), LDL-cholesterol (−38.2%), VLDL-cholesterol (−34.2%), and atherogenic index of plasma (−32.2%), while elevating HDL-cholesterol (+28.2%) (p<0.001 vs. HFD control). Hepatic antioxidant enzymes (SOD, CAT, GPx) were markedly restored and MDA was reduced (−39.5%), surpassing atorvastatin in antioxidant restoration. Liver function markers were significantly normalised. Histopathological examination confirmed attenuation of hepatic steatosis, inflammatory infiltration, and hepatocyte ballooning. Conclusion: The polyherbal extract of A. bourdillonii and C. purpurea demonstrates significant, dose-dependent antihyperlipidemic, antioxidant, and hepatoprotective activities in HFD-induced rats, supporting its potential as a multi-target phytopharmaceutical for hyperlipidaemia management.},
      keywords = {Hyperlipidaemia, Aporosa bourdillonii, Cadia purpurea, Polyherbal extract, High fat diet, Atorvastatin, LDL-cholesterol, Atherogenic index, Antioxidant enzymes, Hepatoprotection.},
      month = {June},
      doi = {https://doi.org/10.64388/IREV9I12-1718799}
  }